BioHealth News Archive
Loyola University Maryland and Wasabi Ventures Name First Business Accelerator Participants – Citybizlist Baltimore
Loyola University Maryland and Wasabi Ventures, a California-based venture capital firm with a presence in Baltimore, named the first three companies participating in the…
Read More
New Enterprise Associates Grabs Four Spots on Forbes Midas List of Top Tech Investors – cbl – Citybizlist Washington DC
Four New Enterprise Associates (NEA) venture capitalists were named to Forbes Midas List of Tech Investors, which aims to single out the top 100…
Read More
Bioeconomy Blueprint Embraces Public-Private Efforts, Avoids Grand Challenges
President Barack Obama’s administration rolled out its National Bioeconomy Blueprint last week, on April 26. It details measures by which Washington intends to apply…
Read More
Pfizer Profit Declines 19% After Loss of Lipitor Patent – NYTimes.com
For years, drug companies have known that their days of plenty were numbered, that the moment would arrive when the best-selling drugs that had…
Read More
States would be wise to emulate New York health accelerator model – FierceMobileHealthcare
It was exciting to see the creation this week of the New York Digital Health Accelerator in New York. The New York State Department…
Read More
BioHealth Innovation, Inc. Appoints Qiagen’s Douglas Liu to Board of Directors
BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced…
Read More
Foundation Seeks Help Identifying Innovators in Vaccine Delivery | Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation is now accepting nominations for the second annual Gates Vaccine Innovation Award. The award aims to recognize, celebrate,…
Read More
Healthcare execs to mentor digital startups in NY ‘accelerator’ program
In a move that combines an interest in improving health outcomes with a desire to create jobs and boost the state economy, the New…
Read More
AstraZeneca CEO to retire amidst double digit losses
David Brennan's move to retire as AstraZeneca's (NYSE:AZN) CEO in June did not come as a surprise to those who had been urging for a…
Read More
NATIONAL BIOECONOMY BLUEPRINT
“The world is shifting to an innovation economy and nobody does innovation better than America.” —President Obama, December 6, 2011 Economic activity that is…
Read More
Drug research: All together now | The Economist
IT WAS once only drug firms that developed drugs. But this is changing. Take the case of the Michael J. Fox Foundation, a Parkinson’s…
Read More
Nodality loses leader to NEA as medical diagnostics model morphs – San Francisco Business Times
Growing diagnostic test developer Nodality Inc. is losing its first CEO, but the venture capital world is gaining another experienced life sciences entrepreneur. Dr.…
Read More
Zyngenia, Inc. Recruits David Parkinson, M.D., as Board Member, Clinical Advisory Board Head, and Interim Chief Medical Officer
Zyngenia, Inc., a biopharmaceutical company developing Zybodies(TM), next-generation multi-specific antibody-based drugs in oncology and immunology, announced today that it has appointed David Parkinson, M.D.…
Read More
University of Maryland BioPark Announces MedImmune’s Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
BALTIMORE, MARYLAND, April 24, 2012 – The University of Maryland BioPark announced today thatBahija Jallal, Ph.D., Executive Vice President of Research and Development at…
Read More
Human Genome Sciences cuts losses – Washington Business Journal
Rockville-based Human Genome Sciences Inc., which last week rejected an unsolicited $2.6 billion acquisition offer by GlaxoSmithKline PLC, reported higher revenue and cut losses…
Read More